- RECOMMENDATIONS OF THE LATIN AMERICAN NETWORK FOR THE STUDY AND TREATMENT OF NEUROPATHIC PAIN
[作者:Rey, R; Arizaga, E; Verdugo, R; Vidal, O; Jreige, A; Juarez, H; Chinchilla, D; Colimon, F,期刊:Drugs of today, 页码:1-33 , 文章类型: Article,,卷期:2011年47-5]
-
- DIFLUPREDNATE FOR INFLAMMATORY EYE DISORDERS
[作者:Mulki, L; Foster, CS,期刊:Drugs of today, 页码:327-333 , 文章类型: Article,,卷期:2011年47-5]
- Uveitis is the third leading cause of preventable blindness in the U.S. Topical administration of corticosteroids remains the mainstay in the management of acute autoimmune anterior uveitis. Difluprednate 0.05% ophthalmi...
- BUCINDOLOL: NEW HOPES FROM REVIEWING PAST DATA
[作者:Fiuzat, M; O'Connor, CM,期刊:Drugs of today, 页码:347-351 , 文章类型: Review,,卷期:2011年47-5]
- beta-Adrenoceptor antagonists or beta-blockers are a cornerstone of therapy in chronic heart failure (CHF). Bucindolol hydrochloride is a fourth-generation beta-blocker in development for the treatment of CHF. Two trials...
|